P2X7 receptor: an emerging target in central nervous system diseases
Abstract
The ATP-sensitive homomeric P2X7 receptor (P2X7R) has received particular attention as a potential drug target because of its widespread involvement in inflammatory diseases as a key regulatory element of the inflammasome complex. However, it has only recently become evident that P2X7Rs also play a pivotal role in central nervous system (CNS) pathology. There is an explosion of data indicating that genetic deletion and pharmacological blockade of P2X7Rs alter responsiveness in animal models of neurological disorders, such as stroke, neurotrauma, epilepsy, neuropathic pain, multiple sclerosis (MS), amyotrophic lateral sclerosis (ALS), Alzheimer's disease, Parkinson's disease, and Huntington's disease. Moreover, recent studies suggest that P2X7Rs regulate the pathophysiology of psychiatric disorders, including mood disorders, implicating P2X7Rs as drug targets in a variety of CNS pathology.
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
Activation of P2X7 receptors induced by viral infection leads to molecular alterations (neuroimmune response activation, ROS formation, and glutamate release), behavioral alterations, and mental disorders.
“their activation induced by viral infection leads to molecular (mainly neuroimmune response activation, reactive oxygen species (ROS) formation, and glutamate release) and behavioral alterations [17, 20] as well as to mental disorders [21].”
From Hyperactivation of P2X7 receptors as a culprit of COVID-19 neuropathology (2021) · cites this paper as [21]
P2X7 receptor activation increases neuroinflammatory responses, which have been associated with neurodegenerative diseases, psychiatric disorders and stroke.
“Remarkably, P2X7 receptor activation increases neuroinflammatory responses, which have been associated with neurodegenerative diseases, psychiatric disorders and stroke [21, 92–95], as further discussed.”
From Hyperactivation of P2X7 receptors as a culprit of COVID-19 neuropathology (2021) · cites this paper as [21]
Purinergic signaling is involved in several psychiatric disorders, including MDD.
“Purinergic signaling is involved in several psychiatric disorders, including MDD [25,26,27,28], and is mediated by nucleoside and nucleotide actions on P1 (P1R) and P2 (P2R) receptors.”
From P2X7 Receptor Signaling in Stress and Depression (2019) · cites this paper as [28]
P2X7R-mediated effects, mainly through activation of the neuroinflammatory response, have been involved in MDD, neurodegenerative diseases, schizophrenia, epilepsy, neuropathic pain, and brain injury.
“P2X7R-mediated effects, which mainly occurs through activation of the neuroinflammatory response, have been involved in MDD, neurodegenerative diseases, schizophrenia, epilepsy, neuropathic pain and brain injury [28,66,67,68].”
From P2X7 Receptor Signaling in Stress and Depression (2019) · cites this paper as [28]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Cites
A Meta-Analysis of Cytokines in Major Depression
Dowlati, Y., Herrmann, N., Swardfager, W., Liu, H., Sham, L., Reim, E. K., & Lanctôt, K. L. (2010) · Biological Psychiatry · doi:10.1016/j.biopsych.2009.09.033 · Cited by 4,729 · see citing works
Altered Cytokine Production in Mice Lacking P2X7Receptors
Solle, M., Labasi, J. M., Perregaux, D. G., Stam, E. J., Petrushova, N., Koller, B. H., Griffiths, R., & Gabel, C. A. (2001) · Journal of Biological Chemistry · doi:10.1074/jbc.m006781200 · Cited by 924 · see citing works
Crystal structure of the ATP-gated P2X4 ion channel in the closed state
Kawate, T., Michel, J. J. C., Birdsong, W. T., & Gouaux, E. (2009) · Nature · doi:10.1038/nature08198 · Cited by 739 · see citing works
The inflammasome: Pathways linking psychological stress, depression, and systemic illnesses
Iwata, M., Ota, K. T., & Duman, R. S. (2013) · Brain, Behavior, and Immunity · doi:10.1016/j.bbi.2012.12.008 · Cited by 580 · see citing works
Transcranial amelioration of inflammation and cell death after brain injury.
Roth, T. L., Nayak, D., Atanasijevic, T., Koretsky, A. P., Latour, L. L., & McGavern, D. B. (2014) · Nature · doi:10.1038/nature12808 · Cited by 574 · see citing works
Molecular mechanism of ATP binding and ion channel activation in P2X receptors
Hattori, M., & Gouaux, E. (2012) · Nature · doi:10.1038/nature11010 · Cited by 554 · see citing works
Peng, W., Cotrina, M. L., Han, X., Yu, H., Bekar, L. K., Blum, L., Takano, T., Tian, G.-F., Goldman, S. A., & Nedergaard, M. (2009) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0902531106 · Cited by 425 · see citing works
Hetero-oligomeric Assembly of P2X Receptor Subunits
Torres, G. E., Egan, T. M., & Voigt, M. M. (1999) · Journal of Biological Chemistry · doi:10.1074/jbc.274.10.6653 · Cited by 414 · see citing works
Matute, C., Torre, I., Pérez‐Cerdá, F., Pérez‐Samartín, A., Alberdi, E. M., Etxebarria, E., Arranz, A. M., Ravid, R., Antigüedad, A. R., Sánchez‐Gómez, M. V., et al. (2007) · Journal of Neuroscience · doi:10.1523/jneurosci.0579-07.2007 · Cited by 404 · see citing works
Monif, M., Reid, C. A., Powell, K. L., Smart, M. L., & Williams, D. A. (2009) · The Journal of Neuroscience · doi:10.1523/jneurosci.5512-08.2009 · Cited by 374 · see citing works
P2X7 receptors in the nervous system
Sperlágh, B., Vizi, E. S., Wirkner, K., & Illés, P. (2006) · Progress in Neurobiology · doi:10.1016/j.pneurobio.2006.03.007 · Cited by 374 · see citing works
Self-citationSorge, R. E., Trang, T., Dorfman, R., Smith, S. B., Beggs, S., Ritchie, J., Austin, J., Zaykin, D. V., Meulen, H. V., Costigan, M., et al. (2012) · Nature Medicine · doi:10.1038/nm.2710 · Cited by 360 · see citing works
Keystone, E. C., Wang, M. M., Layton, M., Hollis, S., & McInnes, I. B. (2012) · Annals of the Rheumatic Diseases · doi:10.1136/annrheumdis-2011-143578 · Cited by 318 · see citing works
Activation of Microglia by Amyloid β Requires P2X7 Receptor Expression
Sanz, J. M., Chiozzi, P., Ferrari, D., Colaianna, M., Idzko, M., Falzoni, S., Fellin, R., Trabace, L., & Di Virgilio, F. (2009) · The Journal of Immunology · doi:10.4049/jimmunol.0803612 · Cited by 293 · see citing works
Deuchars, S. A., Atkinson, L., Brooke, R. E., Musa, H., Milligan, C. J., Batten, T. F. C., Buckley, N. J., Parson, S. H., & Deuchars, J. (2001) · The Journal of Neuroscience · doi:10.1523/jneurosci.21-18-07143.2001 · Cited by 287 · see citing works
North, R. A., & Jarvis, M. F. (2012) · Molecular Pharmacology · doi:10.1124/mol.112.083758 · Cited by 271 · see citing works
Sperlágh, B., Köfalvi, A., Deuchars, J., Atkinson, L., J. Milligan, C., Buckley, N. J., & Vizi, E. S. (2002) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.2002.00920.x · Cited by 264 · see citing works
Self-citationReanalysis of P2X<sub>7</sub>Receptor Expression in Rodent Brain
Sim, J. A., Young, M. T., Sung, H.-Y., North, R. A., & Surprenant, A. (2004) · The Journal of Neuroscience · doi:10.1523/jneurosci.1469-04.2004 · Cited by 264 · see citing works
Trophic activity of a naturally occurring truncated isoform of the P2X7 receptor
Adinolfi, E., Cirillo, M., Woltersdorf, R., Falzoni, S., Chiozzi, P., Pellegatti, P., Callegari, M. G., Sandonà, D., Markwárdt, F., Schmalzing, G., et al. (2010) · The FASEB Journal · doi:10.1096/fj.09-153601 · Cited by 254 · see citing works
Stock, T. C., Bloom, B. J., Wei, N., Ishaq, S., Park, W., WANG, X., Gupta, P. K., & MEBUS, C. A. (2012) · The Journal of Rheumatology · doi:10.3899/jrheum.110874 · Cited by 246 · see citing works
Evidence for Functional P2X4/P2X7 Heteromeric Receptors
Guo, C. Y., Masin, M., Qureshi, O. S., & Murrell‐Lagnado, R. D. (2007) · Molecular Pharmacology · doi:10.1124/mol.107.035980 · Cited by 239 · see citing works
Basso, A. M., Bratcher, N. A., Harris, R. R., Jarvis, M. F., Decker, M. W., & Rueter, L. E. (2009) · Behavioural Brain Research · doi:10.1016/j.bbr.2008.10.018 · Cited by 224 · see citing works
Dı́az-Hernández, M., Diez-Zaera, M., Sánchez‐Nogueiro, J., Gómez‐Villafuertes, R., Canals, J. M., Alberch, J., Miras‐Portugal, M. T., & Lucas, J. J. (2009) · The FASEB Journal · doi:10.1096/fj.08-122275 · Cited by 224 · see citing works
P2X7 receptors mediate ischemic damage to oligodendrocytes
Domercq, M., Perez‐Samartin, A., Aparicio, D., Alberdi, E., Pampliega, O., & Matute, C. (2010) · Glia · doi:10.1002/glia.20958 · Cited by 221 · see citing works
Burnstock, G. (2003) · Current Opinion in Pharmacology · doi:10.1016/j.coph.2003.08.001 · Cited by 216 · see citing works
In vivo P2X7 inhibition reduces amyloid plaques in Alzheimer's disease through GSK3β and secretases
Díaz‐Hernandéz, J. I., Gómez‐Villafuertes, R., León‐Otegui, M., Hontecillas‐Prieto, L., del Puerto, A., Trejo, J. L., Lucas, J. J., Garrido, J. J., Gualix, J., Miras‐Portugal, M. T., et al. (2011) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2011.09.040 · Cited by 201 · see citing works
Bhattacharya, A., Wang, Q., Ao, H., Shoblock, J. R., Lord, B., Aluisio, L. E., Fraser, I. C., Nepomuceno, D. H., Neff, R. A., Welty, N., et al. (2013) · British Journal of Pharmacology · doi:10.1111/bph.12314 · Cited by 200 · see citing works
Connexin and pannexin hemichannels in inflammatory responses of glia and neurons
Bennett, M. V. L., Garré, J. M., Orellana, J. A., Ff, B., Nedergaard, M., Giaume, C., & Sáez, J. C. (2012) · Brain Research · doi:10.1016/j.brainres.2012.08.042 · Cited by 196 · see citing works
Engel, T., Gómez‐Villafuertes, R., Tanaka, K., Mesuret, G., Sanz‐Rodriguez, A., García-Huerta, P., Miras‐Portugal, M. T., Henshall, D. C., & Dı́az-Hernández, M. (2011) · The FASEB Journal · doi:10.1096/fj.11-196089 · Cited by 196 · see citing works
Arbeloa, J., Pérez‐Samartín, A., Gottlieb, M., & Matute, C. (2011) · Neurobiology of Disease · doi:10.1016/j.nbd.2011.12.014 · Cited by 188 · see citing works
Nicke, A., Kuan, Y., Masin, M., Rettinger, J., Marquez-Klaka, B., Bender, O., Górecki, D. C., Murrell‐Lagnado, R. D., & Soto, F. (2009) · Journal of Biological Chemistry · doi:10.1074/jbc.m109.033134 · Cited by 187 · see citing works
Kim, J., & Kang, T. (2011) · Journal of Clinical Investigation · doi:10.1172/jci44818 · Cited by 179 · see citing works
P2x7 deficiency suppresses development of experimental autoimmune encephalomyelitis
Sharp, A. J., Polak, P. E., Simonini, M. V., Lin, S. X., Richardson, J. C., Bongarzone, E. R., & Feinstein, D. L. (2008) · Journal of Neuroinflammation · doi:10.1186/1742-2094-5-33 · Cited by 167 · see citing works
ATP signaling is deficient in cultured pannexin1‐null mouse astrocytes
Suadicani, S. O., Iglesias, R., Wang, J., Dahl, G., Spray, D. C., & Scemes, E. (2012) · Glia · doi:10.1002/glia.22338 · Cited by 162 · see citing works
Gandelman, M., Peluffo, H., Beckman, J. S., Cassina, P., & Barbeito, L. (2010) · Journal of Neuroinflammation · doi:10.1186/1742-2094-7-33 · Cited by 162 · see citing works
The Therapeutic Potential of Modifying Inflammasomes and NOD-Like Receptors
Virgilio, F. D. (2013) · Pharmacological Reviews · doi:10.1124/pr.112.006171 · Cited by 158 · see citing works
Chu, K., Yin, B., Wang, J., Peng, G., Liang, H., Xu, Z., Du, Y., Fang, M., Xia, Q., & Luo, B. (2012) · Journal of Neuroinflammation · doi:10.1186/1742-2094-9-69 · Cited by 156 · see citing works
Xia, J., Lim, J. C.-S., Lu, W., Beckel, J. M., Macarak, E. J., Laties, A. M., & Mitchell, C. H. (2012) · The Journal of Physiology · doi:10.1113/jphysiol.2012.227983 · Cited by 154 · see citing works
P2X7 Receptor Channels Allow Direct Permeation of Nanometer-Sized Dyes
Browne, L. E., Compan, V., Bragg, L., & North, R. A. (2013) · Journal of Neuroscience · doi:10.1523/jneurosci.2235-12.2013 · Cited by 151 · see citing works
Jimenez‐Pacheco, A., Mesuret, G., Sanz‐Rodriguez, A., Tanaka, K., Mooney, C. M., Conroy, R. M., Miras‐Portugal, M. T., Dı́az-Hernández, M., Henshall, D. C., & Engel, T. (2013) · Epilepsia · doi:10.1111/epi.12257 · Cited by 148 · see citing works
Marques-da-Silva, C., Chaves, M. M., Castro, N. G., Coutinho‐Silva, R., & Guimaraes, M. (2011) · British Journal of Pharmacology · doi:10.1111/j.1476-5381.2011.01254.x · Cited by 145 · see citing works
A role for P2X 7 in microglial proliferation
Bianco, F., Ceruti, S., Colombo, A. V., Fumagalli, M., Ferrari, D., Pizzirani, C., Matteoli, M., Virgilio, F. D., Abbracchio, M. P., & Verderio, C. (2006) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2006.04101.x · Cited by 143 · see citing works
The First CNS-Active Carborane: A Novel P2X7 Receptor Antagonist with Antidepressant Activity
Wilkinson, S. M., Gunosewoyo, H., Barron, M. L., Boucher, A. A., McDonnell, M., Turner, P., Morrison, D. E., Bennett, M. R., McGregor, I. S., Rendina, L. M., et al. (2014) · ACS Chemical Neuroscience · doi:10.1021/cn500054n · Cited by 143 · see citing works
P2X7 receptor‐stimulation causes fever <i>via</i> PGE2 and IL‐1β release
Barberà‐Cremades, M., Baroja‐Mazo, A., Gomez, A. I., Machado, F., Di Virgilio, F., & Pelegrín, P. (2012) · The FASEB Journal · doi:10.1096/fj.12-205765 · Cited by 142 · see citing works
Kimbler, D. E., Shields, J., Yanasak, N. E., Vender, J. R., & Dhandapani, K. M. (2012) · PLoS ONE · doi:10.1371/journal.pone.0041229 · Cited by 137 · see citing works
Roger, S., Mei, Z.-Z., Baldwin, J. M., Dong, L., Bradley, H., Baldwin, S. A., Surprenant, A., & Jiang, L. (2009) · Journal of Psychiatric Research · doi:10.1016/j.jpsychires.2009.10.005 · Cited by 131 · see citing works
Chen, L., & Brosnan, C. F. (2006) · The Journal of Immunology · doi:10.4049/jimmunol.176.5.3115 · Cited by 130 · see citing works
do Carmo, M. R. S., Menezes, A. P. F., Nunes, A. C. L., Pliássova, A., Rolo, A. P., Palmeira, C. M., Cunha, R. A., Canas, P. M., & de Andrade, G. M. (2014) · Neuropharmacology · doi:10.1016/j.neuropharm.2014.01.045 · Cited by 129 · see citing works
C terminus of the P2X7 receptor: treasure hunting
Costa‐Junior, H. M., Vieira, F. S., & Coutinho‐Silva, R. (2011) · Purinergic Signalling · doi:10.1007/s11302-011-9215-1 · Cited by 128 · see citing works
Csölle, C., Baranyi, M., Zsilla, G., Kittel, Á., Gölöncsér, F., Illes, P., Papp, E., Vizi, E. S., & Sperlágh, B. (2013) · PLoS ONE · doi:10.1371/journal.pone.0066547 · Cited by 128 · see citing works
Self-citationApolloni, S., Parisi, C., Pesaresi, M. G., Rossi, S., Carrı̀, M. T., Cozzolino, M., Volonté, C., & D’Ambrosi, N. (2013) · The Journal of Immunology · doi:10.4049/jimmunol.1203262 · Cited by 128 · see citing works
Genetics of the P2X7 receptor and human disease
Fuller, S. J., Stokes, L., Skarratt, K. K., Gu, B. J., & Wiley, J. S. (2009) · Purinergic Signalling · doi:10.1007/s11302-009-9136-4 · Cited by 125 · see citing works
Adriouch, S., Bannas, P., Schwarz, N., Fliegert, R., Guse, A. H., Séman, M., Haag, F., & Koch‐Nolte, F. (2007) · The FASEB Journal · doi:10.1096/fj.07-9294com · Cited by 123 · see citing works
Sikora, A. G., Liu, J., Brosnan, C. F., Buell, G. N., Chessel, I., & Bloom, B. R. (1999) · The Journal of Immunology · doi:10.4049/jimmunol.163.2.558 · Cited by 120 · see citing works
Chu, Y., Zhang, Y., Zhang, Y., & Zhao, Z.-Q. (2010) · Brain Behavior and Immunity · doi:10.1016/j.bbi.2010.06.001 · Cited by 117 · see citing works
McQuillin, A., Bass, N. J., Choudhury, K., Puri, V., Kosmin, M., Lawrence, J., Curtis, D., & Gurling, H. (2008) · Molecular Psychiatry · doi:10.1038/mp.2008.6 · Cited by 117 · see citing works
Masin, M., Young, C., Lim, K., Barnes, S. J., Xu, X., Marschall, V., Brutkowski, W., Mooney, E. R., Górecki, D. C., & Murrell‐Lagnado, R. D. (2011) · British Journal of Pharmacology · doi:10.1111/j.1476-5381.2011.01624.x · Cited by 112 · see citing works
Ali, Z., Laurijssens, B. E., Ostenfeld, T., McHugh, S. M., Stylianou, A., Scott‐Stevens, P., Hosking, L. K., Dewit, O., Richardson, J. C., & Chen, C. (2012) · British Journal of Clinical Pharmacology · doi:10.1111/j.1365-2125.2012.04320.x · Cited by 111 · see citing works
Apolloni, S., Amadio, S., Montilli, C., Volonte, C., & D'Ambrosi, N. (2013) · Human Molecular Genetics · doi:10.1093/hmg/ddt259 · Cited by 109 · see citing works
Delarasse, C., Auger, R., Gonnord, P., Fontaine, B., & Kanellopoulos, J. (2010) · Journal of Biological Chemistry · doi:10.1074/jbc.m110.200618 · Cited by 108 · see citing works
Boucher, A. A., Arnold, J. C., Hunt, G. E., Spiro, A., Spencer, J., Brown, C., McGregor, I. S., Bennett, M. R., & Kassiou, M. (2011) · Neuroscience · doi:10.1016/j.neuroscience.2011.05.049 · Cited by 108 · see citing works
Csölle, C., Andó, R. D., Kittel, Á., Gölöncsér, F., Baranyi, M., Soproni, K., Zelena, D., Haller, J., Németh, T., Mócsai, A., et al. (2013) · International Journal of Neuropsychopharmacology · doi:10.1017/s1461145711001933 · Cited by 108 · see citing works
Self-citationHe, W., Cui, J. G., Du, L., Zhao, Y., Burnstock, G., Zhou, H., & Ruan, H. (2011) · Behavioural Brain Research · doi:10.1016/j.bbr.2011.09.015 · Cited by 107 · see citing works
Labrousse, V. F., Costes, L., Aubert, A., Darnaudéry, M., Ferreira, G., Amédée, T., & Layé, S. (2009) · PLoS ONE · doi:10.1371/journal.pone.0006006 · Cited by 106 · see citing works
Zhou, D., Chen, M.-L., Zhang, Y.-Q., & Zhao, Z.-Q. (2010) · Journal of Neuroscience · doi:10.1523/jneurosci.5377-09.2010 · Cited by 105 · see citing works
Jiang, L., Baldwin, J. M., Roger, S., & Baldwin, S. A. (2013) · Frontiers in Pharmacology · doi:10.3389/fphar.2013.00055 · Cited by 105 · see citing works
Chaumont‐Dubel, S., & Khakh, B. S. (2008) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0803008105 · Cited by 104 · see citing works
Positive allosteric modulation by ivermectin of human but not murine P2X7 receptors
Nörenberg, W., Sobottka, H., Hempel, C., Plötz, T., Fischer, W., Schmalzing, G., & Schaefer, M. (2012) · British Journal of Pharmacology · doi:10.1111/j.1476-5381.2012.01987.x · Cited by 102 · see citing works
Marcellino, D., Suárez-Boomgaard, D., Sánchez-Reina, M. D., Aguirre, J. A., Yoshitake, T., Yoshitake, S., Hagman, B., Kehr, J., Agnati, L. F., Fuxe, K., et al. (2010) · Journal of Neural Transmission · doi:10.1007/s00702-010-0400-0 · Cited by 97 · see citing works
Andó, R., Méhész, B., Gyires, K., Illés, P., & Sperlágh, B. (2010) · British Journal of Pharmacology · doi:10.1111/j.1476-5381.2009.00596.x · Cited by 96 · see citing works
Self-citationArnoux, I., Hoshiko, M., Mandavy, L., Avignone, E., Yamamoto, N., & Audinat, É. (2013) · Glia · doi:10.1002/glia.22503 · Cited by 96 · see citing works
P2X7 Is a Scavenger Receptor for Apoptotic Cells in the Absence of Its Ligand, Extracellular ATP
Gu, B. J., Saunders, B. M., Petrou, S., & Wiley, J. S. (2011) · The Journal of Immunology · doi:10.4049/jimmunol.1101178 · Cited by 96 · see citing works
Synaptic localization of P2X7 receptors in the rat retina
Puthussery, T., & Fletcher, E. L. (2004) · The Journal of Comparative Neurology · doi:10.1002/cne.20045 · Cited by 94 · see citing works
Soronen, P., Mantere, O., Melartin, T. K., Suominen, K. H., Vuorilehto, M. S., Rytsälä, H. J., Arvilommi, P., Holma, I. A. K., Holma, M., Jylhä, P. J., et al. (2011) · American Journal of Medical Genetics Part B Neuropsychiatric Genetics · doi:10.1002/ajmg.b.31179 · Cited by 91 · see citing works
ATP and the purine type 2 X7 receptor affect sleep
Krueger, J. M., Taishi, P., De, A., Davis, C. J., Winters, B. D., Clinton, J. M., Szentirmai, É., & Zielinski, M. R. (2010) · Journal of Applied Physiology · doi:10.1152/japplphysiol.00586.2010 · Cited by 89 · see citing works
Doná, F., Ulrich, H., Persike, D. S., Conceição, I. M., Blini, J. P., Cavalheiro, É. A., & Fernandes, M. J. D. S. (2008) · Epilepsy Research · doi:10.1016/j.eplepsyres.2008.10.008 · Cited by 87 · see citing works
The food dye FD&C Blue No. 1 is a selective inhibitor of the ATP release channel Panx1
Wang, J., Jackson, D. G., & Dahl, G. (2013) · The Journal of General Physiology · doi:10.1085/jgp.201310966 · Cited by 86 · see citing works
Tsao, H.-K., Chiu, P.-H., & Sun, S. H. (2013) · Cell Death and Disease · doi:10.1038/cddis.2013.274 · Cited by 83 · see citing works
Oliveira, J. F., Riedel, T., Leichsenring, A., Heine, C., Franke, H., Krügel, U., Nörenberg, W., & Illés, P. (2010) · Cerebral Cortex · doi:10.1093/cercor/bhq154 · Cited by 81 · see citing works
Combating innate inflammation: a new paradigm for acute treatment of stroke?
Stoll, G., Kleinschnitz, C., & Nieswandt, B. (2010) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.2010.05730.x · Cited by 80 · see citing works
Atkinson, L., Batten, T. F. C., Moores, T. S., Varoqui, H., Erickson, J. D., & Deuchars, J. (2004) · Neuroscience · doi:10.1016/j.neuroscience.2003.08.065 · Cited by 80 · see citing works
Chen, S., Ma, Q., Krafft, P. R., Chen, Y., Tang, J., Zhang, J., & Zhang, J. H. (2013) · Critical Care Medicine · doi:10.1097/ccm.0b013e31829a8246 · Cited by 79 · see citing works
Is pannexin the pore associated with the P2X7 receptor?
Alberto, A. V. P., Faria, R. X., Couto, C. G. C., Ferreira, L. G. B., Souza, C. A. M., Teixeira, P. C. N., Fróes, M. M., & Alves, L. A. (2013) · Naunyn-Schmiedeberg s Archives of Pharmacology · doi:10.1007/s00210-013-0868-x · Cited by 78 · see citing works
Clemastine Potentiates the Human P2X7 Receptor by Sensitizing It to Lower ATP Concentrations
Nörenberg, W., Hempel, C., Urban, N. D., Sobottka, H., Illés, P., & Schaefer, M. (2011) · Journal of Biological Chemistry · doi:10.1074/jbc.m110.198879 · Cited by 77 · see citing works
Gain-of-function of P2X7 receptor gene variants in multiple sclerosis
Oyanguren-Desez, O., Antigüedad, A. R., Villoslada, P., Domercq, M., Alberdi, E. M., & Matute, C. (2011) · Cell Calcium · doi:10.1016/j.ceca.2011.08.002 · Cited by 75 · see citing works
Niyadurupola, N., Sidaway, P., Ma, N., Rhodes, J. D., Broadway, D. C., & Sanderson, J. (2013) · Investigative Ophthalmology & Visual Science · doi:10.1167/iovs.12-10968 · Cited by 74 · see citing works
Heinrich, A., Andó, R., Turi, G. F., Rózsa, B. J., & Sperlágh, B. (2012) · British Journal of Pharmacology · doi:10.1111/j.1476-5381.2012.01932.x · Cited by 73 · see citing works
Self-citationXu, X. J., Boumechache, M., Robinson, L. E., Marschall, V., Górecki, D. C., Masin, M., & Murrell‐Lagnado, R. D. (2012) · Journal of Cell Science · doi:10.1242/jcs.099374 · Cited by 71 · see citing works
Marcoli, M., Cervetto, C., Paluzzi, P., Guarnieri, S., Alloisio, S., Thellung, S., Nobile, M., & Maura, G. (2008) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2008.05322.x · Cited by 70 · see citing works
P2X7 receptors at adult neural progenitor cells of the mouse subventricular zone
Messemer, N., Kunert, C., Grohmann, M., Sobottka, H., Nieber, K., Zimmermann, H., Franke, H., Nörenberg, W., Straub, I., Schaefer, M., et al. (2013) · Neuropharmacology · doi:10.1016/j.neuropharm.2013.05.017 · Cited by 70 · see citing works
P2X4 receptors interact with both P2X2 and P2X7 receptors in the form of homotrimers
Antonio, L., Stewart, A. P., Xu, X., Varanda, W. A., Murrell‐Lagnado, R. D., & Edwardson, J. M. (2011) · British Journal of Pharmacology · doi:10.1111/j.1476-5381.2011.01303.x · Cited by 69 · see citing works
P2X receptor antagonists for pain management: examination of binding and physicochemical properties
Gum, R. J., Wakefield, B. D., & Jarvis, M. F. (2011) · Purinergic Signalling · doi:10.1007/s11302-011-9272-5 · Cited by 67 · see citing works
P2X7 Antagonists as Potential Therapeutic Agents for the Treatment of CNS Disorders
Chrovian, C. C., Rech, J. C., Bhattacharya, A., & Letavic, M. A. (2014) · Progress in medicinal chemistry · doi:10.1016/b978-0-444-63380-4.00002-0 · Cited by 67 · see citing works
Mitochondrial dysfunction is involved in P2X7 receptor‐mediated neuronal cell death
Nishida, K., Nakatani, T., Ohishi, A., Okuda, H., Higashi, Y., Matsuo, T., Fujimoto, S., & Nagasawa, K. (2012) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2012.07868.x · Cited by 66 · see citing works
Contribution of Pannexin1 to Experimental Autoimmune Encephalomyelitis
Lutz, S. E., González‐Fernández, E., Ventura, J. C. C., Pérez‐Samartín, A., Tarassishin, L., Negoro, H., Patel, N. K., Suadicani, S. O., Lee, S. C., Matute, C., et al. (2013) · PLoS ONE · doi:10.1371/journal.pone.0066657 · Cited by 65 · see citing works
Kim, J.-E., Ryu, H. J., Yeo, S., & Kang, T. (2010) · Journal of Neuroinflammation · doi:10.1186/1742-2094-7-65 · Cited by 63 · see citing works
García-Huerta, P., Dı́az-Hernández, M., Delicado, E. G., Pimentel-Santillana, M., Miras‐Portugal, M. T., & Gómez‐Villafuertes, R. (2012) · Journal of Biological Chemistry · doi:10.1074/jbc.m112.390971 · Cited by 62 · see citing works
Wang, L., Cai, W., Chen, P., Deng, Q., & Cong-min, Z. (2008) · Glia · doi:10.1002/glia.20758 · Cited by 61 · see citing works
Dual Gating Mechanism and Function of P2X7 Receptor Channels
Khadra, A., Tomić, M., Yan, Z., Zemkova, H. W., Sherman, A., & Stojilković, S. S. (2013) · Biophysical Journal · doi:10.1016/j.bpj.2013.05.006 · Cited by 60 · see citing works
Ficker, C., Rozmer, K., Kató, E., Andó, R. D., Schumann, L., Krügel, U., Franke, H., Sperlágh, B., Riedel, T., & Illés, P. (2014) · Glia · doi:10.1002/glia.22707 · Cited by 59 · see citing works
Self-citationdel Puerto, A., Fronzaroli‐Molinières, L., Pérez-Álvarez, M. J., Giraud, P., Carlier, E., Wandosell, F. G., Debanne, D., & Garrido, J. J. (2014) · Cerebral Cortex · doi:10.1093/cercor/bhu035 · Cited by 58 · see citing works
Connexin hemichannel and pannexin channel electrophysiology: How do they differ?
Patel, D., Zhang, X., & Veenstra, R. D. (2014) · FEBS Letters · doi:10.1016/j.febslet.2013.12.023 · Cited by 57 · see citing works
P2X7 receptor‐induced death of motor neurons by a peroxynitrite/ FAS ‐dependent pathway
Gandelman, M., Levy, M., Cassina, P., Barbeito, L., & Beckman, J. S. (2013) · Journal of Neurochemistry · doi:10.1111/jnc.12286 · Cited by 57 · see citing works
The role of purinergic signaling in depressive disorders.
Sperlágh, B., Csölle, C., Andó, R. D., Gölöncsér, F., Kittel, Á., & Baranyi, M. (2012) · PubMed · Cited by 56 · see citing works
Self-citationSchwarz, N., Drouot, L., Nicke, A., Fliegert, R., Boyer, O., Guse, A. H., Haag, F., Adriouch, S., & Koch‐Nolte, F. (2012) · PLoS ONE · doi:10.1371/journal.pone.0041269 · Cited by 56 · see citing works
Itoh, K., Chiang, C., Li, Z., Lee, J., Dostrovsky, J. O., & Sessle, B. J. (2011) · Neuroscience · doi:10.1016/j.neuroscience.2011.06.083 · Cited by 56 · see citing works
P2X7 Receptors Trigger ATP Exocytosis and Modify Secretory Vesicle Dynamics in Neuroblastoma Cells
Gutiérrez-Martı́n, Y., Bustillo, D., Gómez‐Villafuertes, R., Sánchez‐Nogueiro, J., Torregrosa‐Hetland, C. J., Binz, T., Gutiérrez, L. M., Miras‐Portugal, M. T., & Artalejo, A. R. (2011) · Journal of Biological Chemistry · doi:10.1074/jbc.m110.139410 · Cited by 55 · see citing works
Bradley, H., Baldwin, J. M., Goli, G. R., Johnson, B., Zou, J., Sivaprasadarao, A., Baldwin, S. A., & Jiang, L. (2011) · Journal of Biological Chemistry · doi:10.1074/jbc.m110.211284 · Cited by 55 · see citing works
Grigoroiu‐Serbânescu, M., Herms, S., Mühleisen, T. W., Georgi, A., Diaconu, C. C., Strohmaier, J., Czerski, P. M., Hauser, J., Leszczyńska-Rodziewicz, A., Jamra, R. A., et al. (2009) · American Journal of Medical Genetics Part B Neuropsychiatric Genetics · doi:10.1002/ajmg.b.30952 · Cited by 55 · see citing works
P2X receptors as targets for the treatment of status epilepticus
Henshall, D. C., Dı́az-Hernández, M., Miras‐Portugal, M. T., & Engel, T. (2013) · Frontiers in Cellular Neuroscience · doi:10.3389/fncel.2013.00237 · Cited by 54 · see citing works
Involvement of RVM-expressed P2X7 receptor in bone cancer pain: Mechanism of descending facilitation
Huang, Z. X., Lu, Z. J., Ma, W. Q., Wu, F. X., Zhang, Y. Q., Yu, W., & Zhao, Z. Q. (2014) · Pain · doi:10.1016/j.pain.2014.01.011 · Cited by 54 · see citing works
ATP‐P2X7receptor signaling controls basal and TNFα‐stimulated glial cell proliferation
Zou, J., Vetreno, R. P., & Crews, F. T. (2012) · Glia · doi:10.1002/glia.22302 · Cited by 53 · see citing works
Electrophysiological classification of P2X7 receptors in rat cultured neocortical astroglia
Nörenberg, W., Schunk, J., Fischer, W., Sobottka, H., Riedel, T., Oliveira, J. F., Franke, H., & Illés, P. (2010) · British Journal of Pharmacology · doi:10.1111/j.1476-5381.2010.00736.x · Cited by 52 · see citing works
Chen, Y., Li, G., & Huang, L.-Y. M. (2012) · Molecular Pain · doi:10.1186/1744-8069-8-9 · Cited by 51 · see citing works
Cognitive manic symptoms associated with the P2RX7 gene in bipolar disorder
Backlund, L., Nikamo, P., Hukic, D. S., Ek, I. R., Träskman‐Bendz, L., Landén, M., Edman, G., Schalling, M., Frisén, L., & Ösby, U. (2011) · Bipolar Disorders · doi:10.1111/j.1399-5618.2011.00952.x · Cited by 50 · see citing works
Hracskó, Z., Baranyi, M., Csölle, C., Gölöncsér, F., Madarász, E., Kittel, Á., & Sperlágh, B. (2011) · Molecular Neurodegeneration · doi:10.1186/1750-1326-6-28 · Cited by 50 · see citing works
Self-citationActivation of Trimeric P2X2 Receptors by Fewer than Three ATP Molecules
Stelmashenko, O., Lalo, U., Yue, Y., Bragg, L., North, R. A., & Compan, V. (2012) · Molecular Pharmacology · doi:10.1124/mol.112.080903 · Cited by 50 · see citing works
The P2 Receptor Antagonist PPADS Supports Recovery from Experimental Stroke In Vivo
Lämmer, A., Beck, A., Grummich, B., Förschler, A., Krügel, T., Kahn, T., Schneider, D., Illés, P., Franke, H., & Krügel, U. (2011) · PLoS ONE · doi:10.1371/journal.pone.0019983 · Cited by 49 · see citing works
Gölöncsér, F., & Sperlágh, B. (2014) · The Journal of Headache and Pain · doi:10.1186/1129-2377-15-24 · Cited by 49 · see citing works
Self-citationAble, S., Fish, R., Bye, H., Booth, L. A., Logan, Y. R., Nathaniel, C., Hayter, P. M., & KATUGAMPOLA, S. D. (2010) · British Journal of Pharmacology · doi:10.1111/j.1476-5381.2010.01025.x · Cited by 47 · see citing works
Modulation/physiology of calcium channel sub-types in neurosecretory terminals
Lémos, J. R., Ortiz‐Miranda, S., Cuadra, A. E., Velázquez‐Marrero, C., Custer, E. E., Dad, T., & Dayanithi, G. (2012) · Cell Calcium · doi:10.1016/j.ceca.2012.01.008 · Cited by 47 · see citing works
The P2X7‐Egr pathway regulates nucleotide‐dependent inflammatory gene expression in microglia
Friedle, S. A., Brautigam, V. M., Nikodémová, M., Wright, M. L., & Watters, J. J. (2010) · Glia · doi:10.1002/glia.21071 · Cited by 45 · see citing works
Viikki, M., Kampman, O., Anttila, S. A. K., Illi, A., Setälä-Soikkeli, E., Huuhka, M., Mononen, N., Lehtimäki, T. J., & Leinonen, E. V. J. (2011) · Neuroscience Letters · doi:10.1016/j.neulet.2011.02.023 · Cited by 44 · see citing works
Kim, J., Ryu, H. J., & Kang, T. (2011) · Journal of Neuroinflammation · doi:10.1186/1742-2094-8-62 · Cited by 44 · see citing works
ALS: Focus on purinergic signalling
Volonté, C., Apolloni, S., Carrı̀, M. T., & D’Ambrosi, N. (2011) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2011.06.002 · Cited by 44 · see citing works
Synaptic terminals from mice midbrain exhibit functional P2X7 receptor
Marín‐García, P., Sánchez‐Nogueiro, J., Gómez‐Villafuertes, R., León, D., & Miras‐Portugal, M. T. (2007) · Neuroscience · doi:10.1016/j.neuroscience.2007.10.038 · Cited by 40 · see citing works
Yu, Q., Guo, Z., Liu, X., Ouyang, Q., He, C., Burnstock, G., Yuan, H., & Xiang, Z. (2013) · Purinergic Signalling · doi:10.1007/s11302-013-9379-y · Cited by 40 · see citing works
Potentiation of Inhibitory Synaptic Transmission by Extracellular ATP in Rat Suprachiasmatic Nuclei
Bhattacharya, A., Vávra, V., Svobodová, I., Bendová, Z., Vereb, G., & Zemkova, H. W. (2013) · Journal of Neuroscience · doi:10.1523/jneurosci.4682-12.2013 · Cited by 39 · see citing works
Kim, J., Kwak, S., Jo, S., & Kang, T. (2009) · Neurological Research · doi:10.1179/174313209x389811 · Cited by 39 · see citing works
Hempel, C., Nörenberg, W., Sobottka, H., Urban, N. D., Nicke, A., Fischer, W., & Schaefer, M. (2013) · Neuropharmacology · doi:10.1016/j.neuropharm.2013.07.027 · Cited by 39 · see citing works
Chen, X., Pierce, B. S., Naing, W., Grapperhaus, M. L., & Phillion, D. P. (2010) · Bioorganic & Medicinal Chemistry Letters · doi:10.1016/j.bmcl.2010.03.094 · Cited by 39 · see citing works
Marcillo, A. E., Frydel, B. R., Bramlett, H. M., & Dietrich, W. D. (2011) · Experimental Neurology · doi:10.1016/j.expneurol.2011.06.008 · Cited by 38 · see citing works
Amadio, S., Apolloni, S., D’Ambrosi, N., & Volonté, C. (2011) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2010.07025.x · Cited by 37 · see citing works
P2X7 receptors enhance glutamate release in hippocampal hilar neurons
Cho, J.-H., Choi, I.-S., & Jang, I.-S. (2010) · Neuroreport · doi:10.1097/wnr.0b013e32833d9142 · Cited by 37 · see citing works
The Second Transmembrane Domain of P2X7 Contributes to Dilated Pore Formation
Sun, C., Heid, M. E., Keyel, P. A., & Salter, R. D. (2013) · PLoS ONE · doi:10.1371/journal.pone.0061886 · Cited by 37 · see citing works
Csölle, C., & Sperlágh, B. (2009) · Journal of Neuroimmunology · doi:10.1016/j.jneuroim.2009.11.011 · Cited by 36 · see citing works
Self-citationCarrasquero, L. M. G., Delicado, E. G., Sánchez‐Ruiloba, L., Iglesias, T., & Miras‐Portugal, M. T. (2010) · Glia · doi:10.1002/glia.20980 · Cited by 36 · see citing works
Synthesis and biological activity of a series of tetrasubstituted-imidazoles as P2X7 antagonists
Gleave, R. J., Walter, D. S., Beswick, P., Fonfría, E., Michel, A. D., Roman, S. A., & Tang, S.-P. (2010) · Bioorganic & Medicinal Chemistry Letters · doi:10.1016/j.bmcl.2010.05.018 · Cited by 33 · see citing works
Grygorowicz, T., Strużyńska, L., Sułkowski, G., Chalimoniuk, M., & Sulejczak, D. (2010) · Neurochemistry International · doi:10.1016/j.neuint.2010.08.021 · Cited by 33 · see citing works
Girotti, P. A., Misawa, R., Palombit, K., Mendes, C. E., Bittencourt, J. C., & Castelucci, P. (2013) · Cell and Tissue Research · doi:10.1007/s00441-013-1620-z · Cited by 33 · see citing works
Ito, G., Suekawa, Y., Watanabe, M., Takahashi, K., Inubushi, T., Murasaki, K., Hirose, N., Hiyama, S., Uchida, T., & Tanne, K. (2012) · European Journal of Pain · doi:10.1002/j.1532-2149.2012.00174.x · Cited by 32 · see citing works
P2X7 receptors regulate engulfing activity of non-stimulated resting astrocytes
Yamamoto, M., Kamatsuka, Y., Ohishi, A., Nishida, K., & Nagasawa, K. (2013) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2013.08.022 · Cited by 32 · see citing works
Dynamic micro-organization of P2X7 receptors revealed by PALM based single particle tracking
Shrivastava, A. N., Rodriguez, P. C., Triller, A., & Renner, M. L. (2013) · Frontiers in Cellular Neuroscience · doi:10.3389/fncel.2013.00232 · Cited by 32 · see citing works
Variation in the purinergic P2RX7 receptor gene and schizophrenia
Hansen, T. F., Jakobsen, K. D., Fenger, M., Nielsen, J., Krane, K., Fink‐Jensen, A., Lublin, H., Ullum, H., Timm, S., Wang, A. G., et al. (2008) · Schizophrenia Research · doi:10.1016/j.schres.2008.05.026 · Cited by 31 · see citing works
Natural compounds with P2X7 receptor-modulating properties
Fischer, W., Urban, N. D., Immig, K., Franke, H., & Schaefer, M. (2013) · Purinergic Signalling · doi:10.1007/s11302-013-9392-1 · Cited by 31 · see citing works
Identification of 2-oxo-N-(phenylmethyl)-4-imidazolidinecarboxamide antagonists of the P2X7 receptor
Abberley, L., Bebius, A., Beswick, P., Billinton, A., Collis, K. L., Dean, D. K., Fonfría, E., Gleave, R. J., Medhurst, S. J., Michel, A. D., et al. (2010) · Bioorganic & Medicinal Chemistry Letters · doi:10.1016/j.bmcl.2010.09.101 · Cited by 31 · see citing works
The P2X7 receptor as a route for non‐exocytotic glutamate release: dependence on the carboxyl tail
Cervetto, C., Alloisio, S., Frattaroli, D., Mazzotta, M. C., Milanese, M., Gavazzo, P., Passalacqua, M., Nobile, M., Maura, G., & Marcoli, M. (2013) · Journal of Neurochemistry · doi:10.1111/jnc.12143 · Cited by 29 · see citing works
Calmidazolium selectively inhibits exocytotic glutamate release evoked by P2X7 receptor activation
Cervetto, C., Mazzotta, M. C., Frattaroli, D., Alloisio, S., Nobile, M., Maura, G., & Marcoli, M. (2012) · Neurochemistry International · doi:10.1016/j.neuint.2012.02.034 · Cited by 29 · see citing works
Kongsui, R., Beynon, S. B., Johnson, S. J., Mayhew, J., Kuter, P., Nilsson, M., & Walker, F. R. (2014) · Brain Behavior and Immunity · doi:10.1016/j.bbi.2014.05.017 · Cited by 29 · see citing works
Chambers, L. J., Stevens, A. J., Moses, A. P., Michel, A. D., Walter, D. S., Davies, D. J., Livermore, D. G., Fonfría, E., Demont, E. H., Vimal, M., et al. (2010) · Bioorganic & Medicinal Chemistry Letters · doi:10.1016/j.bmcl.2010.03.096 · Cited by 29 · see citing works
Fu, W., Ruangkittisakul, A., MacTavish, D., Baker, G. B., Ballanyi, K., & Jhamandas, J. H. (2013) · Neuroscience · doi:10.1016/j.neuroscience.2013.07.029 · Cited by 28 · see citing works
Purinergic responses of calcium-dependent signaling pathways in cultured adult human astrocytes
Hashioka, S., Wang, Y. F., Little, J. P., Choi, H. B., Klegeris, A., McGeer, P. L., & McLarnon, J. G. (2014) · BMC Neuroscience · doi:10.1186/1471-2202-15-18 · Cited by 27 · see citing works
Beswick, P., Billinton, A., Chambers, L. J., Dean, D. K., Fonfría, E., Gleave, R. J., Medhurst, S. J., Michel, A. D., Moses, A. P., Patel, S., et al. (2010) · Bioorganic & Medicinal Chemistry Letters · doi:10.1016/j.bmcl.2010.05.107 · Cited by 27 · see citing works
Kim, J., Kim, D., Ryu, H. J., Kim, W. I., Kim, M., Kim, D. W., Choi, S. Y., & Kang, T. (2013) · Hippocampus · doi:10.1002/hipo.22109 · Cited by 26 · see citing works
Potentiation of the glutamatergic synaptic input to rat locus coeruleus neurons by P2X7 receptors
Khakpay, R., Polster, D., Köles, L., Skorinkin, A., Szabo, B., Wirkner, K., & Illes, P. (2010) · Purinergic Signalling · doi:10.1007/s11302-010-9198-3 · Cited by 24 · see citing works
Discovery, synthesis and SAR of azinyl- and azolylbenzamides antagonists of the P2X7 receptor
Subramanyam, C., Duplantier, A. J., Dombroski, M. A., Chang, S.-P., Gabel, C. A., Whitney‐Pickett, C., Perregaux, D. G., Labasi, J. M., Yoon, K., Shepard, R. M., et al. (2011) · Bioorganic & Medicinal Chemistry Letters · doi:10.1016/j.bmcl.2011.06.117 · Cited by 20 · see citing works
Evidence for two conductive pathways in P2X7 receptor: differences in modulation and selectivity
Alloisio, S., Garbo, A. D., Barbieri, R., Bozzo, L., Ferroni, S., & Nobile, M. (2010) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2010.06649.x · Cited by 17 · see citing works
Habbas, S., Ango, F., Daniel, H., & Galante, M. (2011) · Glia · doi:10.1002/glia.21224 · Cited by 17 · see citing works
Milius, D., Sperlágh, B., & Illés, P. (2008) · Neuroscience Letters · doi:10.1016/j.neulet.2008.09.023 · Cited by 15 · see citing works
Self-citationCorrection: Contribution of Pannexin1 to Experimental Autoimmune Encephalomyelitis
Lutz, S. E., González‐Fernández, E., Ventura, J. C. C., Pérez‐Samartín, A., Tarassishin, L., Negoro, H., Patel, N. K., Suadicani, S. O., Lee, S. C., Matute, C., et al. (2013) · PLoS ONE · doi:10.1371/annotation/cedbee08-9c0e-42e3-862f-df7409c273ef · Cited by 15 · see citing works
D’Amico, M., Samengo, I. A., Navarra, P., Taglialatela, M., & Martire, M. (2010) · Neurochemistry International · doi:10.1016/j.neuint.2010.07.009 · Cited by 14 · see citing works
Cuadra, A. E., Custer, E. E., Bosworth, E., & Lémos, J. R. (2013) · Journal of Cellular Physiology · doi:10.1002/jcp.24453 · Cited by 10 · see citing works
Flagged first, then by citations
2 of the 164 references couldn’t be matched to a known paper.
Cited by
Sorted by citations
The P2X7 Receptor in Inflammatory Diseases: Angel or Demon?
Savio, L. E. B., de Andrade Mello, P., da Silva, C. G., & Coutinho-Silva, R. (2018) · Frontiers in Pharmacology · doi:10.3389/fphar.2018.00052 · Cited by 437 · see citing works
Purinergic Signalling: Therapeutic Developments
Burnstock, G. (2017) · Frontiers in Pharmacology · doi:10.3389/fphar.2017.00661 · Cited by 401 · see citing works
Yue, N., Huang, H., Zhu, X., Han, Q., Wang, Y., Li, B., Liu, Q., Wu, G., Zhang, Y., & Yu, J. (2017) · Journal of Neuroinflammation · doi:10.1186/s12974-017-0865-y · Cited by 334 · see citing works
Purine and purinergic receptors
Burnstock, G. (2018) · Brain and Neuroscience Advances · doi:10.1177/2398212818817494 · Cited by 330 · see citing works
Structural basis for subtype-specific inhibition of the P2X7 receptor
Karasawa, A., & Kawate, T. (2016) · eLife · doi:10.7554/elife.22153 · Cited by 308 · see citing works
Microglia in Alzheimer’s disease: pathogenesis, mechanisms, and therapeutic potentials
Miao, J., Ma, H., Yang, Y., Liao, Y., Lin, C., Zheng, J., Yu, M., & Lan, J. (2023) · Frontiers in Aging Neuroscience · doi:10.3389/fnagi.2023.1201982 · Cited by 293 · see citing works
Thawkar, B. S., & Kaur, G. (2018) · Journal of Neuroimmunology · doi:10.1016/j.jneuroim.2018.11.010 · Cited by 247 · see citing works
Burnstock, G., & Knight, G. E. (2018) · Purinergic Signalling · doi:10.1007/s11302-017-9593-0 · Cited by 248 · see citing works
The Dual Role of Microglia in ALS: Mechanisms and Therapeutic Approaches
Geloso, M. C., Corvino, V., Marchese, E., Serrano, A., Michetti, F., & D’Ambrosi, N. (2017) · Frontiers in Aging Neuroscience · doi:10.3389/fnagi.2017.00242 · Cited by 239 · see citing works
Regulation of Microglial Functions by Purinergic Mechanisms in the Healthy and Diseased CNS
Illés, P., Rubini, P., Ulrich, H., Zhao, Y., & Tang, Y. (2020) · Cells · doi:10.3390/cells9051108 · Cited by 235 · see citing works
Sluyter, R. (2017) · Advances in Experimental Medicine and Biology · doi:10.1007/5584_2017_59 · Cited by 235 · see citing works
The microglial ATP‐gated ion channel P2X7 as a CNS drug target
Bhattacharya, A., & Biber, K. (2016) · Glia · doi:10.1002/glia.23001 · Cited by 221 · see citing works
P2X7 Interactions and Signaling – Making Head or Tail of It
Kopp, R., Krautloher, A., Ramírez-Fernández, A., & Nicke, A. (2019) · Frontiers in Molecular Neuroscience · doi:10.3389/fnmol.2019.00183 · Cited by 217 · see citing works
Re-evaluation of neuronal P2X7 expression using novel mouse models and a P2X7-specific nanobody
Kaczmarek-Hájek, K., Zhang, J., Kopp, R., Grosche, A., Rissiek, B., Saul, A., Bruzzone, S., Engel, T., Jooss, T., Durner, A., et al. (2018) · eLife · doi:10.7554/elife.36217 · Cited by 210 · see citing works
Burnstock, G. (2015) · Neuropharmacology · doi:10.1016/j.neuropharm.2015.05.031 · Cited by 200 · see citing works
Masuda, T., Ozono, Y., Mikuriya, S., Kohro, Y., Tozaki‐Saitoh, H., Iwatsuki, K., Uneyama, H., Ichikawa, R., Salter, M. W., Tsuda, M., et al. (2016) · Nature Communications · doi:10.1038/ncomms12529 · Cited by 182 · see citing works
Fekete, R., Cserép, C., Lénárt, N., Tóth, K., Orsolits, B., Martinecz, B., Méhes, E., Szabó, B., Németh, V., Gönci, B., et al. (2018) · Acta Neuropathologica · doi:10.1007/s00401-018-1885-0 · Cited by 184 · see citing works
Self-citationNeuronal P2X7 Receptors Revisited: Do They Really Exist?
Illes, P., Khan, T. M., & Rubini, P. (2017) · The Journal of Neuroscience · doi:10.1523/jneurosci.3103-16.2017 · Cited by 179 · see citing works
Feng, L., Chen, Y., Ding, R., Fu, Z., Yang, S., Deng, X., & Zeng, J. (2015) · Journal of Neuroinflammation · doi:10.1186/s12974-015-0409-2 · Cited by 170 · see citing works
Jimenez‐Pacheco, A., Dı́az-Hernández, M., Arribas-Blázquez, M., Sanz‐Rodriguez, A., Olivos-Oré, L. A., Artalejo, A. R., Alves, M., Letavic, M. A., Miras‐Portugal, M. T., Conroy, R. M., et al. (2016) · Journal of Neuroscience · doi:10.1523/jneurosci.4009-15.2016 · Cited by 161 · see citing works
The NLRP3 inflammasome and COVID-19: Activation, pathogenesis and therapeutic strategies
Zhao, N., Di, B., & Xu, L. (2021) · Cytokine & Growth Factor Reviews · doi:10.1016/j.cytogfr.2021.06.002 · Cited by 156 · see citing works
Zhang, Q.-S., Heng, Y., Yuan, Y.-H., & Chen, N.-H. (2017) · Toxicology Letters · doi:10.1016/j.toxlet.2016.11.002 · Cited by 156 · see citing works
The P2X7 Receptor Primes IL-1β and the NLRP3 Inflammasome in Astrocytes Exposed to Mechanical Strain
Albalawi, F., Lu, W., Beckel, J. M., Lim, J. C., McCaughey, S. A., & Mitchell, C. H. (2017) · Frontiers in Cellular Neuroscience · doi:10.3389/fncel.2017.00227 · Cited by 155 · see citing works
Advances in the Potential Biomarkers of Epilepsy
Kobylarek, D., Iwanowski, P. S., Lewandowska, Z., Limphaibool, N., Szafranek, S., Labrzycka, A., & Kozubski, W. P. (2019) · Frontiers in Neurology · doi:10.3389/fneur.2019.00685 · Cited by 153 · see citing works
Role of neuro-immunological factors in the pathophysiology of mood disorders
Bhattacharya, A., Derecki, N. C., Lovenberg, T. W., & Drevets, W. C. (2016) · Psychopharmacology · doi:10.1007/s00213-016-4214-0 · Cited by 149 · see citing works
Hyperactivation of P2X7 receptors as a culprit of COVID-19 neuropathology
Ribeiro, D. E., Oliveira-Giacomelli, Á., Glaser, T., Arnaud-Sampaio, V. F., Andrejew, R., Dieckmann, L., Baranova, J., Lameu, C., Ratajczak, M. Z., & Ulrich, H. (2021) · Molecular Psychiatry · doi:10.1038/s41380-020-00965-3 · Cited by 145 · see citing works
P2X7 receptor mediates NLRP3 inflammasome activation in depression and diabetes
Wang, D., Wang, H., Gao, H., Zhang, H., Zhang, H., Wang, Q., & Sun, Z. (2020) · Cell & Bioscience · doi:10.1186/s13578-020-00388-1 · Cited by 145 · see citing works
P2X7 Receptors Amplify CNS Damage in Neurodegenerative Diseases
Illés, P. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21175996 · Cited by 141 · see citing works
Microglia and the Purinergic Signaling System
Calovi, S., Mut-Arbona, P., & Sperlágh, B. (2018) · Neuroscience · doi:10.1016/j.neuroscience.2018.12.021 · Cited by 133 · see citing works
Self-citationInflammasomes as therapeutic targets for A lzheimer's disease
White, C., Lawrence, C. B., Brough, D., & Rivers‐Auty, J. (2016) · Brain Pathology · doi:10.1111/bpa.12478 · Cited by 131 · see citing works
P2X7 Receptor Signaling in Stress and Depression
Ribeiro, D. E., Roncalho, A. L., Glaser, T., Ulrich, H., Wegener, G., & Joca, S. (2019) · International Journal of Molecular Sciences · doi:10.3390/ijms20112778 · Cited by 129 · see citing works
The therapeutic potential of purinergic signalling
Burnstock, G. (2017) · Biochemical Pharmacology · doi:10.1016/j.bcp.2017.07.016 · Cited by 127 · see citing works
Principles of inflammasome priming and inhibition: implications for psychiatric disorders
Herman, F. J., & Pasinetti, G. M. (2018) · Brain, Behavior, and Immunity · doi:10.1016/j.bbi.2018.06.010 · Cited by 115 · see citing works
Recent advances in CNS P2X7 physiology and pharmacology: Focus on neuropsychiatric disorders
Bhattacharya, A. (2018) · Frontiers in Pharmacology · doi:10.3389/fphar.2018.00030 · Cited by 115 · see citing works
P2X7 Receptor as a Therapeutic Target
Marchi, E. D., Orioli, E., Ben, D. D., & Adinolfi, E. (2016) · Advances in protein chemistry and structural biology · doi:10.1016/bs.apcsb.2015.11.004 · Cited by 111 · see citing works
Curcumin in Depression: Potential Mechanisms of Action and Current Evidence—A Narrative Review
Ramaholimihaso, T., Bouazzaoui, F., & Kaladjian, A. (2020) · Frontiers in Psychiatry · doi:10.3389/fpsyt.2020.572533 · Cited by 114 · see citing works
Astroglia-Derived ATP Modulates CNS Neuronal Circuits
Illés, P., Burnstock, G., & Tang, Y. (2019) · Trends in Neurosciences · doi:10.1016/j.tins.2019.09.006 · Cited by 104 · see citing works
Jimenez-Mateos, E. M., Arribas-Blazquez, M., Sanz-Rodriguez, A., Concannon, C., Olivos-Ore, L. A., Reschke, C. R., Mooney, C. M., Mooney, C., Lugara, E., Morgan, J., et al. (2015) · Scientific Reports · doi:10.1038/srep17486 · Cited by 94 · see citing works
Targeting NLRP3 Inflammasome in the Treatment of CNS Diseases
Shao, B., Cao, Q., & Chong, L. (2018) · Frontiers in Molecular Neuroscience · doi:10.3389/fnmol.2018.00320 · Cited by 102 · see citing works
Peng, Y., Chu, S., Yang, Y., Zhang, Z., Pang, Z., & Chen, N. (2021) · Frontiers in Pharmacology · doi:10.3389/fphar.2021.671734 · Cited by 102 · see citing works
ATP and adenosine—Two players in the control of seizures and epilepsy development
Beamer, E. H., Kuchukulla, M., Boison, D., & Engel, T. (2021) · Progress in Neurobiology · doi:10.1016/j.pneurobio.2021.102105 · Cited by 99 · see citing works
The ATP-Gated P2X7 Receptor As a Target for the Treatment of Drug-Resistant Epilepsy
Beamer, E. H., Fischer, W., & Engel, T. (2017) · Frontiers in Neuroscience · doi:10.3389/fnins.2017.00021 · Cited by 100 · see citing works
Yue, N., Li, B., Yang, L., Han, Q.-Q., Huang, H.-J., Wang, Y.-L., Wang, J., Yu, R., Wu, G.-C., Liu, Q., et al. (2018) · Frontiers in Molecular Neuroscience · doi:10.3389/fnmol.2018.00149 · Cited by 100 · see citing works
P2X7 receptor: A potential therapeutic target for autoimmune diseases
Cao, F., Hu, L., Yao, S.-R., Hu, Y., Wang, D., Fan, Y., Pan, G., Tao, S., Zhang, Q., Pan, H., et al. (2019) · Autoimmunity Reviews · doi:10.1016/j.autrev.2019.06.009 · Cited by 98 · see citing works
Vanda, D., Zajdel, P., & Soural, M. (2019) · European Journal of Medicinal Chemistry · doi:10.1016/j.ejmech.2019.111569 · Cited by 97 · see citing works
Calzaferri, F., Ruiz‐Ruiz, C., de Diego, A. M. G., de Pascual, R., Méndez‐López, I., Cano‐Abad, M. F., Maneu, V., Rı́os, C. D. L., Gandı́a, L., & de Diego, A. M. G. (2020) · Medicinal Research Reviews · doi:10.1002/med.21710 · Cited by 98 · see citing works
P2X7 Receptor: A Potential Therapeutic Target for Depression?
Deussing, J. M., & Arzt, E. (2018) · Trends in Molecular Medicine · doi:10.1016/j.molmed.2018.07.005 · Cited by 97 · see citing works
Tang, Y., Yin, H., Rubini, P., & Illés, P. (2016) · The Neuroscientist · doi:10.1177/1073858416654453 · Cited by 95 · see citing works
Glutamate-induced and NMDA receptor-mediated neurodegeneration entails P2Y1 receptor activation
Simões, A. P., Silva, C. G., Marques, J. M., Pochmann, D., Porciúncula, L. O., Ferreira, S., Oses, J. P., Beleza, R. O., Real, J. I., Köfalvi, A., et al. (2018) · Cell Death and Disease · doi:10.1038/s41419-018-0351-1 · Cited by 95 · see citing works
Koole, M. J. B., Schmidt, M. E., Hijzen, A., Ravenstijn, P. G. M., Vandermeulen, C., Weehaeghe, D. V., Serdons, K., Celen, S., Bormans, G. M., Ceusters, M., et al. (2018) · Journal of Nuclear Medicine · doi:10.2967/jnumed.118.216747 · Cited by 95 · see citing works
ATPergic signalling during seizures and epilepsy
Engel, T., Alves, M., Sheedy, C., & Henshall, D. C. (2015) · Neuropharmacology · doi:10.1016/j.neuropharm.2015.11.001 · Cited by 95 · see citing works
Purinergic receptors in psychiatric disorders
Krügel, U. (2015) · Neuropharmacology · doi:10.1016/j.neuropharm.2015.10.032 · Cited by 95 · see citing works
Metzger, M. W., Walser, S. M., Aprile-Garcia, F., Dedic, N., Chen, A., Holsboer, F., ARZT, E. S., Wurst, W., & Deussing, J. M. (2016) · Purinergic Signalling · doi:10.1007/s11302-016-9546-z · Cited by 92 · see citing works
Purinergic receptors in embryonic and adult neurogenesis
Oliveira‐Giacomelli, Á., Illés, P., & Ulrich, H. (2015) · Neuropharmacology · doi:10.1016/j.neuropharm.2015.10.008 · Cited by 88 · see citing works
ATP-Gated P2X Receptor Channels: Molecular Insights into Functional Roles
Schmid, R., & Evans, R. J. (2018) · Annual Review of Physiology · doi:10.1146/annurev-physiol-020518-114259 · Cited by 86 · see citing works
Connexins and pannexins: At the junction of neuro‐glial homeostasis & disease
Lapato, A. S., & Tiwari-Woodruff, S. K. (2017) · Journal of Neuroscience Research · doi:10.1002/jnr.24088 · Cited by 85 · see citing works
Zhao, H., Zhang, X., Dai, Z., Feng, Y., Li, Q., Zhang, J. H., Liu, X., Chen, Y., & Feng, H. (2016) · Scientific Reports · doi:10.1038/srep23286 · Cited by 84 · see citing works
Farooq, R. K., Tanti, A., Ainouche, S., Roger, S., Belzung, C., & Camus, V. (2018) · Psychoneuroendocrinology · doi:10.1016/j.psyneuen.2018.07.016 · Cited by 83 · see citing works
Wang, X., Xie, X., Luo, X., Shang, H., & He, Z. (2016) · Molecular Medicine Reports · doi:10.3892/mmr.2016.6070 · Cited by 83 · see citing works
Extracellular ATP mediates inflammatory responses in colitis via P2 × 7 receptor signaling
Wan, P., Liu, X., Xiong, Y., Ren, Y., Jiang, C., Lü, N., Guo, Y., & Bai, A. (2016) · Scientific Reports · doi:10.1038/srep19108 · Cited by 83 · see citing works
Masuch, A., Shieh, C., van Rooijen, N., van Calker, D., & Biber, K. (2016) · Glia · doi:10.1002/glia.22904 · Cited by 81 · see citing works
Critical Evaluation of P2X7 Receptor Antagonists in Selected Seizure Models
Fischer, W., Franke, H., Krügel, U., Müller, H., Dinkel, K., Lord, B., Letavic, M. A., Henshall, D. C., & Engel, T. (2016) · PLoS ONE · doi:10.1371/journal.pone.0156468 · Cited by 81 · see citing works
Fumagalli, M., Lecca, D., & Abbracchio, M. P. (2015) · Neuropharmacology · doi:10.1016/j.neuropharm.2015.10.005 · Cited by 81 · see citing works
Serum amyloid A primes microglia for ATP-dependent interleukin-1β release
Facci, L., Barbierato, M., Zusso, M., Skaper, S. D., & Giusti, P. (2018) · Journal of Neuroinflammation · doi:10.1186/s12974-018-1205-6 · Cited by 79 · see citing works
Xu, P., Xu, Y., Hu, B., Wang, J., Pan, R., Murugan, M., Wu, L., & Tang, Y. (2015) · Brain Behavior and Immunity · doi:10.1016/j.bbi.2015.06.020 · Cited by 76 · see citing works
Sekar, P., Huang, D.-Y., Hsieh, S.-L. E., Chang, S., & Lin, W. (2018) · Cell Communication and Signaling · doi:10.1186/s12964-018-0293-3 · Cited by 80 · see citing works
Regulation of P2X7 receptor expression and function in the brain
Jimenez-Mateos, E. M., Smith, J., Nicke, A., & Engel, T. (2018) · Brain Research Bulletin · doi:10.1016/j.brainresbull.2018.12.008 · Cited by 79 · see citing works
Pathological ATPergic Signaling in Major Depression and Bipolar Disorder
Illés, P., Verkhratsky, A., & Tang, Y. (2020) · Frontiers in Molecular Neuroscience · doi:10.3389/fnmol.2019.00331 · Cited by 77 · see citing works
Synthesis of [11C]GSK1482160 as a new PET agent for targeting P2X7 receptor
Gao, M., Wang, M., Green, M. A., Hutchins, G. D., & Zheng, Q. (2015) · Bioorganic & Medicinal Chemistry Letters · doi:10.1016/j.bmcl.2015.03.021 · Cited by 77 · see citing works
Cellular mechanisms of peroxynitrite-induced neuronal death
Ramdial, K., Franco, M. C., & Estévez, Á. G. (2017) · Brain Research Bulletin · doi:10.1016/j.brainresbull.2017.05.008 · Cited by 75 · see citing works
P2X7 Receptor-Associated Programmed Cell Death in the Pathophysiology of Hemorrhagic Stroke
Zhao, H., Chen, Y., & Feng, H. (2018) · Current Neuropharmacology · doi:10.2174/1570159x16666180516094500 · Cited by 74 · see citing works
Huang, C. Y., Chi, X., Li, R., Hu, X., Xu, H.-X., Li, J., & Zhou, D. (2017) · Journal of Molecular Neuroscience · doi:10.1007/s12031-017-0968-z · Cited by 71 · see citing works
Han, J., Liu, H., Liu, C., Jin, H., Perlmutter, J. S., Egan, T. M., & Tu, Z. (2017) · Nuclear Medicine Communications · doi:10.1097/mnm.0000000000000660 · Cited by 71 · see citing works
Dual-Specificity Phosphatase Regulation in Neurons and Glial Cells
Pérez‐Sen, R., Queipo, M. J., Gil‐Redondo, J. C., Ortega, F., Gómez‐Villafuertes, R., Miras‐Portugal, M. T., & Delicado, E. G. (2019) · International Journal of Molecular Sciences · doi:10.3390/ijms20081999 · Cited by 71 · see citing works
Nucleotides in neuroregeneration and neuroprotection
Miras‐Portugal, M. T., Gómez‐Villafuertes, R., Gualix, J., Díaz‐Hernandéz, J. I., Artalejo, A. R., Ortega, F., Delicado, E. G., & Pérez‐Sen, R. (2015) · Neuropharmacology · doi:10.1016/j.neuropharm.2015.09.002 · Cited by 70 · see citing works
Purinergic contribution to amyotrophic lateral sclerosis
Volonté, C., Apolloni, S., Parisi, C., & Amadio, S. (2015) · Neuropharmacology · doi:10.1016/j.neuropharm.2015.10.026 · Cited by 70 · see citing works
Pan, H., Chou, Y., & Sun, S. H. (2015) · Glia · doi:10.1002/glia.22790 · Cited by 70 · see citing works
Garré, J. M., Yang, G., Bukauskas, F. F., & Bennett, M. V. L. (2016) · Journal of Neuroscience · doi:10.1523/jneurosci.4195-15.2016 · Cited by 68 · see citing works
Territo, P. R., & Zarrinmayeh, H. (2021) · Frontiers in Cellular Neuroscience · doi:10.3389/fncel.2021.617036 · Cited by 68 · see citing works
Campagno, K. E., Lu, W., Jassim, A. H., Albalawi, F., Cenaj, A., Tso, H., Clark, S. P., Sripinun, P., Gómez, N. M., & Mitchell, C. H. (2021) · Journal of Neuroinflammation · doi:10.1186/s12974-021-02251-7 · Cited by 67 · see citing works
Mitochondrial targeting as a novel therapy for stroke
Borlongan, C., Russo, E., Nguyen, H., Lippert, T., Tuazon, J. P., & Napoli, E. (2018) · Brain Circulation · doi:10.4103/bc.bc_14_18 · Cited by 67 · see citing works
Heitzer, M., Kaiser, S., Kanagaratnam, M., Zendedel, A., Hartmann, P., Beyer, C., & Johann, S. (2017) · Molecular Neurobiology · doi:10.1007/s12035-016-0322-4 · Cited by 69 · see citing works
P2X7 receptor cross-talk regulates ATP-induced pannexin 1 internalization
Boyce, A. K. J., & Swayne, L. A. (2017) · Biochemical Journal · doi:10.1042/bcj20170257 · Cited by 63 · see citing works
Asatryan, L., Ostrovskaya, O. I., Lieu, D. K., & Davies, D. L. (2017) · Neuropharmacology · doi:10.1016/j.neuropharm.2017.09.030 · Cited by 63 · see citing works
Fantoni, E., Ben, D. D., Falzoni, S., Virgilio, F. D., Lovestone, S., & Gee, A. D. (2017) · EJNMMI Research · doi:10.1186/s13550-017-0275-2 · Cited by 62 · see citing works
Structural and Functional Basis for Understanding the Biological Significance of P2X7 Receptor
Martínez-Cuesta, M. Á., Blanch‐Ruiz, M. A., Ortega‐Luna, R., Sánchez‐López, A., & Álvarez, Á. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21228454 · Cited by 62 · see citing works
Involvement of P2X7 receptors in chronic pain disorders
Ren, W., & Illés, P. (2021) · Purinergic Signalling · doi:10.1007/s11302-021-09796-5 · Cited by 62 · see citing works
Sebastián‐Serrano, Á., Engel, T., de Diego-García, L., Olivos-Oré, L. A., Arribas-Blázquez, M., Martínez-Frailes, C., Pérez-Díaz, C., Millán, J. L., Artalejo, A. R., Miras‐Portugal, M. T., et al. (2016) · Human Molecular Genetics · doi:10.1093/hmg/ddw248 · Cited by 63 · see citing works
Astrocytic and Oligodendrocytic P2X7 Receptors Determine Neuronal Functions in the CNS
Zhao, Y., Tang, Y., & Illés, P. (2021) · Frontiers in Molecular Neuroscience · doi:10.3389/fnmol.2021.641570 · Cited by 59 · see citing works
Neuron–astrocyte interactions in neurodegenerative diseases: Role of neuroinflammation
Rao, K. V. R., & Kielian, T. (2015) · Clinical and Experimental Neuroimmunology · doi:10.1111/cen3.12237 · Cited by 59 · see citing works
Metzger, M. W., Walser, S. M., Dedic, N., Aprile-Garcia, F., Jakubcakova, V., Adamczyk, M., Webb, K. J., Uhr, M., Refojo, D., Schmidt, M. V., et al. (2017) · The Journal of Neuroscience · doi:10.1523/jneurosci.3487-16.2017 · Cited by 59 · see citing works
Köles, L., Kató, E., Hanuska, A., Zádori, Z., Al‐Khrasani, M., Zelles, T., Rubini, P., & Illés, P. (2015) · Purinergic Signalling · doi:10.1007/s11302-015-9480-5 · Cited by 59 · see citing works
Connexins and pannexins in neuronal development and adult neurogenesis
Swayne, L. A., & Bennett, S. A. L. (2016) · BMC Cell Biology · doi:10.1186/s12860-016-0089-5 · Cited by 57 · see citing works
P2X7 receptors drive poly(I:C) induced autism-like behavior in mice
Horváth, G., Otrokocsi, L., Bekő, K., Baranyi, M., Kittel, Á., Fritz-Ruenes, P. A., & Sperlágh, B. (2019) · Journal of Neuroscience · doi:10.1523/jneurosci.1895-18.2019 · Cited by 56 · see citing works
Self-citationA novel radioligand for the ATP-gated ion channel P2X7: [3H] JNJ-54232334
Lord, B., Ameriks, M. K., Wang, Q., Fourgeaud, L., Vliegen, M., Verluyten, W. L. M., Haspeslagh, P., Carruthers, N. I., Lovenberg, T. W., Bonaventure, P., et al. (2015) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2015.09.026 · Cited by 55 · see citing works
The inflammasome as a target for pain therapy
Zhang, H., Li, F., Li, W.-W., Stary, C. M., Clark, J. D., Xu, S., & Xiong, X. (2016) · British Journal of Anaesthesia · doi:10.1093/bja/aew376 · Cited by 56 · see citing works
Differential expression of P2X7 receptor and IL-1β in nociceptive and neuropathic pain
Luchting, B., Heyn, J., Woehrle, T., Rachinger-Adam, B., Kreth, S., Hinske, L. C., & Azad, S. C. (2016) · Journal of Neuroinflammation · doi:10.1186/s12974-016-0565-z · Cited by 54 · see citing works
Kolb, H. C., Barret, O., Bhattacharya, A., Chen, G., Constantinescu, C. C., Huang, C., Letavic, M. A., Tamagnan, G. D., Xia, C. A., Zhang, W., et al. (2019) · Journal of Nuclear Medicine · doi:10.2967/jnumed.118.212696 · Cited by 55 · see citing works
Morgan, J., Alves, M., Conte, G., Menéndez‐Méndez, A., de Diego-García, L., de Leo, G., Beamer, E. H., Smith, J., Nicke, A., & Engel, T. (2020) · Neuroscience Bulletin · doi:10.1007/s12264-020-00573-9 · Cited by 55 · see citing works
Palmitoylation as a Functional Regulator of Neurotransmitter Receptors
Naumenko, V. S., & Ponimaskin, E. G. (2018) · Neural Plasticity · doi:10.1155/2018/5701348 · Cited by 55 · see citing works
- Authors
- Sperlágh, B., & Illes, P.
- Affiliations
- HUN-REN Institute of Experimental Medicine (HU)
- Corresponding author
- Sperlágh, Beáta
- ORCID
- Sperlágh, Beáta
- Venue
- Trends in Pharmacological Sciences
- Publisher
- Elsevier BV
- Published
- 2014-10
- Volume
- 35
- Issue
- 10
- Pages
- 537-547
- ISSN
- 0165-6147 (ISSN-L)
- OpenAlex
- W2133942268
- Cited by
- 390
- References
- 164
- Citations by year
- 2026: 21 · 2025: 20 · 2024: 35 · 2023: 25 · 2022: 32 · 2021: 30 · 2020: 37 · 2019: 35 · 2018: 43 · 2017: 44 · 2016: 38 · 2015: 27 · 2014: 3
- FWCI
- 4.52
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Trends in Pharmacological Sciences (publishedVersion)
- PubMed (publishedVersion)
- Repository of the Academy's Library (Library of the Hungarian Academy of Sciences) (acceptedVersion)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Physiology › Adenosine and Purinergic Signaling
- Health Sciences › Medicine › Physiology › Pain Mechanisms and Treatments
- Health Sciences › Medicine › Neurology › Traumatic Brain Injury and Neurovascular Disturbances
- Keywords
- P2X7 receptor, ATP, central nervous system disorders, inflammasome, neuroinflammation, stroke, neurotrauma, epilepsy, neuropathic pain, multiple sclerosis, amyotrophic lateral sclerosis, Alzheimer's disease, Parkinson's disease, Huntington's disease, mood disorders, therapeutic target
- MeSH terms
- Animals, Mental Disorders, Humans, Neurodegenerative Diseases, Receptors, Purinergic P2X7, Purinergic P2X Receptor Antagonists
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review